What did Olympus Partners pay for EyeSouth Partners?

Olympus Partners acquired EyeSouth Partners for $975.0M in 2022 (13.0x EBITDA), equivalent to 1.60x revenue. Target revenue was approximately $600.0M. Target EBITDA was approximately $75.0M.

What does EyeSouth Partners do?

EyeSouth Partners is a medical practice specialty business.

What multiple did Olympus Partners pay for EyeSouth Partners?

13.0x EBITDA and 1.60x revenue, based on disclosed deal value of $975.0M and disclosed financials.

M&A TRANSACTION · 2022

EyeSouth Partners acquired by Olympus Partners

$975.0M· 13.0x EBITDA· 1.60x revenue

Target

EyeSouth Partners

Acquirer

Olympus Partners

Disclosed financials at time of acquisition

Revenue

$600.0M

EBITDA

$75.0M

Deal Value

$975.0M

EV/EBITDA

13.0x

Context

This $975.0M acquisition of EyeSouth Partners by Olympus Partners sits in the medical practice specialty sub-vertical. The 13.0x EBITDA multiple paid in 2022 can be compared against the population median for medical practice specialty transactions of similar size on our Medical Practice Specialty valuation hub.

Source

Data sourced from Press reporting. All figures reflect disclosed values at the time of the acquisition; no estimated or imputed data. Methodology

Value your own medical practice specialty

Get an instant valuation range for your business. Backed by 25,592 real M&A transactions.

Compare your business to the EyeSouth Partners acquisition.

Citation: ExitValue.ai. (2022). EyeSouth Partners acquired by Olympus Partners. https://exitvalue.ai/deals/eyesouth-partners-acquired-by-olympus-partners-hc-2022-0061